| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 677308 | 73322 | BROMAZEPAM KERN PHARMA 1,5 mg CAPSULAS EFG | BROMAZEPAM KERN PHARMA 1,5 mg CAPSULAS EFG, 30 cápsulas | 1,5 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73322/73322_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73322/73322_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 677311 | 73321 | BROMAZEPAM KERN PHARMA 3 mg CAPSULAS EFG | BROMAZEPAM KERN PHARMA 3 mg CAPSULAS EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73321/73321_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73321/73321_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 603564 | 73132 | BROMAZEPAM NORMON 1,5 mg CAPSULAS DURAS EFG | BROMAZEPAM NORMON 1,5 mg CAPSULAS DURAS EFG, 500 cápsulas | 1,5 mg | 5 | 500 | 43 | 500 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73132/73132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73132/73132_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-12-01 | 1 | 1 | 1 | 2010-12-01 | 2010-12-01 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 672900 | 73132 | BROMAZEPAM NORMON 1,5 mg CAPSULAS DURAS EFG | BROMAZEPAM NORMON 1,5 mg CAPSULAS DURAS EFG, 30 cápsulas | 1,5 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73132/73132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73132/73132_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-12-01 | 1 | 1 | 1 | 2010-12-01 | 2010-12-01 | 1 | 2011-03-07 | Lista IV | View Edit Delete | |||||||||||
| 603565 | 73133 | BROMAZEPAM NORMON 3 mg CAPSULAS DURAS EFG | BROMAZEPAM NORMON 3 mg CAPSULAS DURAS EFG, 500 cápsulas | 3 mg | 5 | 500 | 43 | 500 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73133/73133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73133/73133_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-12-01 | 1 | 1 | 1 | 2010-12-01 | 2010-12-01 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 672901 | 73133 | BROMAZEPAM NORMON 3 mg CAPSULAS DURAS EFG | BROMAZEPAM NORMON 3 mg CAPSULAS DURAS EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73133/73133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73133/73133_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-12-01 | 1 | 1 | 1 | 2010-12-01 | 2010-12-01 | 1 | 2011-03-07 | Lista IV | View Edit Delete | |||||||||||
| 672902 | 73129 | BROMAZEPAM NORMON 6 mg CAPSULAS DURAS EFG | BROMAZEPAM NORMON 6 mg CAPSULAS DURAS EFG , 20 cápsulas | 6 mg | 5 | 20 | 43 | 20 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73129/73129_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73129/73129_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-12-01 | 1 | 1 | 1 | 2010-12-01 | 2010-12-01 | 1 | 2011-03-07 | Lista IV | View Edit Delete | |||||||||||
| 677313 | 73319 | BROMAZEPAM PENSA 3 mg CAPSULAS EFG | BROMAZEPAM PENSA 3 mg CAPSULAS EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73319/73319_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73319/73319_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2012-02-29 | Lista IV | View Edit Delete | |||||||||||
| 653830 | 67561 | BROMURO DE IPRATROPIO ALDO-UNION 250 microgramos/ml SOLUCION PARA INHALACION POR NEBULIZADOR | BROMURO DE IPRATROPIO ALDO-UNION 250 microgramos/ml SOLUCION PARA INHALACION POR NEBULIZADOR , 20 ampollas de 1 ml | 250 microgramos | 1 | 20 | 40 | 20 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67561/67561_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67561/67561_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2006-02-15 | 1 | 1 | 1 | 2006-02-15 | 2006-02-15 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 663046 | 70939 | BROMURO DE IPRATROPIO ALDO-UNION 500 microgramos SOLUCION PARA INHALACION POR NEBULIZADOR | BROMURO DE IPRATROPIO ALDO-UNION 500 microgramos SOLUCION PARA INHALACION POR NEBULIZADOR, 20 ampollas de 2 ml | 500 microgramos | 37 | 20 | 40 | 20 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70939/70939_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70939/70939_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2009-05-20 | 1 | 1 | 1 | 2009-05-20 | 2009-05-20 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 757412 | 87927 | BROMURO DE IPRATROPIO/SALBUTAMOL GENETIC 0,5 MG/2,5 MG SOLUCION PARA INHALACION POR NEBULIZADOR | BROMURO DE IPRATROPIO/SALBUTAMOL GENETIC 0,5 MG/2,5 MG SOLUCION PARA INHALACION POR NEBULIZADOR, 20 ampollas | 2,5 mg/0,5 mg | 1 | 20 | 40 | 20 ampollas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87927/87927_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87927/87927_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16741 | MABO FARMA S.A. | 2022-07-01 | 1 | 1 | 1 | 2022-07-02 | 2022-07-01 | 1 | 2025-05-07 | View Edit Delete | ||||||||||||
| 767040 | 90175 | BRONCHICLEAR SOLUCION ORAL | BRONCHICLEAR SOLUCION ORAL, 1 frasco de 100 ml | 490 mg/ml + 49 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90175/90175_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90175/90175_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11470 | BIONORICA SE | 2025-02-25 | 1 | 1 | 1 | 2025-02-26 | 2025-02-25 | 1 | 2025-10-08 | View Edit Delete | ||||||||||||
| 721192 | 82992 | BRONCHIPRET COMPRIMIDOS RECUBIERTOS CON PELICULA | BRONCHIPRET COMPRIMIDOS RECUBIERTOS CON PELICULA, 20 comprimidos | 60 mg + 160 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82992/82992_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82992/82992_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 11470 | BIONORICA SE | 2018-03-23 | 1 | 1 | 1 | 2018-03-24 | 2018-03-23 | 1 | 2019-10-22 | View Edit Delete | ||||||||||||
| 711643 | 112760 | BRONCHITOL 40 MG POLVO PARA INHALACION, CAPSULAS DURAS | BRONCHITOL 40 MG POLVO PARA INHALACION, CAPSULAS DURAS, 10 cápsulas + 1 inhalador | 40 mg | 5 | 10 | 8 | 10 cápsulas + 1 inhalador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112760/112760_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112760/112760_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29992 | CHIESI ESPAÑA S.A.U. | 2016-07-15 | 1 | 1 | 1 | 2016-07-16 | 2016-07-15 | 0 | 2017-11-28 | View Edit Delete | ||||||||||||
| 711644 | 112760 | BRONCHITOL 40 MG POLVO PARA INHALACION, CAPSULAS DURAS | BRONCHITOL 40 MG POLVO PARA INHALACION, CAPSULAS DURAS, 28 x 10 cápsulas + 2 inhaladores | 40 mg | 5 | 280 | 8 | 28 x 10 cápsulas + 2 inhaladores | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112760/112760_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112760/112760_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29992 | CHIESI ESPAÑA S.A.U. | 2016-07-15 | 1 | 1 | 1 | 2016-07-16 | 2016-07-15 | 0 | 2017-11-28 | View Edit Delete | ||||||||||||
| 720532 | 82816 | BRONCHOGRIP POLVO PARA SOLUCION ORAL | BRONCHOGRIP POLVO PARA SOLUCION ORAL, 10 sobres | 500 mg/10 mg/200 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82816/82816_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82816/82816_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28863 | NO PROCEDE | 2019-01-17 | 1 | 1 | 1 | 2019-01-17 | 2019-01-17 | 1 | 2019-08-06 | View Edit Delete | ||||||||||||
| 715521 | 81922 | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE PASTILLAS BLANDAS | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE PASTILLAS BLANDAS, 20 pastillas | 51,1 mg/4,5 mg | 5 | 20 | 29 | 20 pastillas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81922/81922_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81922/81922_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14258 | OMEGA PHARMA ESPAÑA, S.A. | 2017-04-03 | 1 | 1 | 1 | 2017-04-04 | 2017-04-03 | 1 | 2019-08-06 | View Edit Delete | ||||||||||||
| 704070 | 79116 | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE SOLUCION ORAL | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE SOLUCION ORAL , 1 frasco de 200 ml | 120 mg/15 ml + 830 mg/15 ml | 6 | 200 | 26 | 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79116/79116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79116/79116_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14258 | OMEGA PHARMA ESPAÑA, S.A. | 2014-10-20 | 1 | 1 | 1 | 2014-10-20 | 2014-10-30 | 1 | 2015-10-06 | View Edit Delete | ||||||||||||
| 727076 | 84557 | BRONCHOSTOP NITE SOLUCION ORAL | BRONCHOSTOP NITE SOLUCION ORAL, 1 frasco de 120 ml | 12,5 mg/ml + 9,09 mg/ml + 10 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84557/84557_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84557/84557_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14258 | KWIZDA PHARMA GMBH | 2020-11-20 | 1 | 1 | 1 | 2020-11-20 | 2020-11-20 | 1 | 2021-09-23 | View Edit Delete | ||||||||||||
| 987537 | 50456 | BRONCOMEDICAL CON SULFOGUAYACOL 2MG/ML + 10MG/ML JARABE | BRONCOMEDICAL CON SULFOGUAYACOL 2MG/ML + 10MG/ML JARABE, 1 frasco de 180 ml | 10 mg/5 ml + 50 mg/5 ml | 6 | 180 | 26 | 1 frasco de 180 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/50456/50456_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/50456/50456_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1778 | MEDICAL S.A. | 1972-09-01 | 1 | 1 | 1 | 2012-10-10 | 2012-10-10 | 1 | 2012-01-09 | View Edit Delete |
Page 152 of 1035, showing 20 records out of 20697 total, starting on record 3021, ending on 3040